This framework organizes the key distinctions to guide your conversation with your provider
Vakili, H., Jin, Y., Nagy, J
For me it does exactly what it's supposed to do, keeps the many physical & mental symptoms of PA at bay
This information, combined with your clinical history, biomarker trends (HbA1c, lipid panel, GLP-1 levels where available), and tolerability profile, creates a more complete picture supporting shared decision-making about whether transitioning to compounded tirzepatide serves your long-term metabolic goals
Who Gets NSCP NSCP can affect people of all ages, but it is most common in adults under age 50
It analyzes pathway-level variants (GLP1R, GIPR, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction